Clinical Trial Update: A Study of APS03118 in Advanced Solid Tumors Harboring RET Mutations or Fusions [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of APS03118 in advanced solid tumors harboring RET mutations or fusions, with recruitment status listed as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• APS03118

Snippet

Sponsor: Applied Pharmaceutical Science, Inc. | Conditions: RET-altered Solid Tumors | Phase 1 | Status: ACTIVE_NOT_RECRUITING